Preparation and Characterization of Cabamazepine Cocrystal in Polymer Solution.

about

Preparation and Characterization of Cabamazepine Cocrystal in Polymer Solution.

Item

http://www.wikidata.org/entity/Q47294973

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Preparation and Characterization of Cabamazepine Cocrystal in Polymer Solution.

@en

Preparation and Characterization of Cabamazepine Cocrystal in Polymer Solution.

@nl

type

Item

label

Preparation and Characterization of Cabamazepine Cocrystal in Polymer Solution.

@en

Preparation and Characterization of Cabamazepine Cocrystal in Polymer Solution.

@nl

prefLabel

Preparation and Characterization of Cabamazepine Cocrystal in Polymer Solution.

@en

Preparation and Characterization of Cabamazepine Cocrystal in Polymer Solution.

@nl

P1476

Preparation and Characterization of Cabamazepine Cocrystal in Polymer Solution

@en

P2093

Hao Zhang

http://www.w3.org/2001/XMLSchema#string

Linghuan Gao

http://www.w3.org/2001/XMLSchema#string

Yang Chen

http://www.w3.org/2001/XMLSchema#string

Ying Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone.

Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25.

Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.

Pharmaceutical co-crystals.

Enhancing the bioavailability of magnolol in rabbits using melting solid dispersion with polyvinylpyrrolidone.

Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.

Polymorphism in Carbamazepine Cocrystals

The role of cocrystals in pharmaceutical science.

Pharmaceutical Cocrystals and Their Physicochemical Properties.

Pharmaceutical cocrystals: an overview.

P31

scholarly article

P356

10.3390/PHARMACEUTICS9040054

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ning Qiao

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29194387

http://www.w3.org/2001/XMLSchema#string

P932

5750660

http://www.w3.org/2001/XMLSchema#string